Target intelligence / Profile preview

Plectin (None)

Target
None
Molecular classification
Cytoskeletal protein, Cytolinker (Plakin family), Structural protein
01

Overview

Plectin is a giant, multidomain cytoskeletal protein (∼500 kDa) that acts as an essential crosslinker, connecting intermediate filaments, microtubules, and actin filaments across a wide variety of mammalian tissues[1][2][3][7][8]. It is the prototypical member of the plakin family and is structurally composed of N-terminal actin-binding domains, a central coiled-coil rod domain allowing dimerization, and a C-terminal filament-binding region[2][5][7]. Plectin binds and anchors cytoskeletal networks to junctional complexes (e.g., hemidesmosomes, desmosomes), organelles, and cell membrane sites, thus stabilizing cell architecture, maintaining tissue integrity, and allowing cells to withstand mechanical stress[1][2][3][7][8][10]. Its widespread expression and structural role underpin its involvement in diseases of mechanical fragility such as skin blistering disorders, muscular dystrophies, and certain cancers, typically due to gene mutations rather than as a therapeutic drug target[9].

Other names
Plectin-1PLEC (gene symbol)Cytolinker protein plectinPlakin family protein
02

Biological functions

Cytoskeletal organization and cross-linkingMechanical stabilization of cells and tissuesAnchorage of intermediate filaments to junctional complexes (hemidesmosomes, desmosomes)Association with nucleus, mitochondria, and plasma membrane domainsMaintains viscoelastic properties of tissues
03

Disease associations

Skin diseases (e.g., Epidermolysis bullosa simplex with muscular dystrophy)Muscular dystrophiesNeuropathiesCancer (association via expression levels and cell adhesion but not as a drug target)
04

Safety considerations

Therapeutic challenges are not reported due to lack of direct targetingMutations can cause multi-system pathology affecting skin, muscle, nerves
05

Biomarkers

Diagnostic marker for diseases such as Epidermolysis bullosa simplex (mutation analysis in PLEC)

Beyond the preview

Go deeper on Plectin (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plectin (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call